Longitudinal changes in ferritin during chronic transfusion

A report from the stroke prevention trial in sickle cell anemia (STOP)

Beatrice Files, Don Brambilla, Abdullah Kutlar, Scott Miller, Elliott Vichinsky, Winfred Wang, Suzanne Granger, Robert J. Adams

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose: Chronic red cell transfusion has been used for prevention of recurrent stroke in patients with sickle cell disease for three decades, and its effectiveness in primary prevention was recently shown. Iron overload, the inevitable result of chronic transfusion, is commonly monitored with serum ferritin concentration. Patients and Methods: Sixty-one patients at high risk for stroke received chronic transfusion in a clinical trial of stroke prevention. A serum ferritin level of less than 500 ng/mL was required for study entry. Ferritin levels were obtained quarterly. Fifty patients who had four or more ferritin measurements were included in this analysis. Transfusions were administered as exchange or simple, with washed, reconstituted, or packed red blood cells, at the discretion of the site investigator. Results: Serum ferritin levels increased linearly with cumulative transfusion volume during the first four ferritin measurements, but the rate of increase varied widely among patients. Rates of increase varied similarly among 23 patients who received exclusively simple transfusion with packed red cells and in five patients who received exchange transfusions. Thirty-two patients received a total transfusion volume of more than 250 mL/kg. Ferritin continued to increase linearly after the first four measurements in 14, but the remaining 18 experienced a plateau before the level reached 3,000 ng/mL. Six of those with a linear increase never reached a ferritin level of 3,000 ng/dL. Conclusions: There was strong intrapatient correlation between serum ferritin levels and volume transfused but wide interpatient variability early during chronic transfusion therapy. Intrapatient correlation declined at transfusion volumes of more than 250 mL/kg. Direct iron store assessment is needed to determine the clinical significance of serum ferritin variability.

Original languageEnglish (US)
Pages (from-to)284-290
Number of pages7
JournalJournal of Pediatric Hematology/Oncology
Volume24
Issue number4
DOIs
StatePublished - May 23 2002

Fingerprint

Sickle Cell Anemia
Ferritins
Stroke
Serum
Iron Overload
Primary Prevention
Iron
Erythrocytes
Research Personnel
Clinical Trials

Keywords

  • Chronic transfusion
  • Iron overload
  • Serum ferritin
  • Sickle cell anemia
  • Stroke

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Longitudinal changes in ferritin during chronic transfusion : A report from the stroke prevention trial in sickle cell anemia (STOP). / Files, Beatrice; Brambilla, Don; Kutlar, Abdullah; Miller, Scott; Vichinsky, Elliott; Wang, Winfred; Granger, Suzanne; Adams, Robert J.

In: Journal of Pediatric Hematology/Oncology, Vol. 24, No. 4, 23.05.2002, p. 284-290.

Research output: Contribution to journalArticle

Files, Beatrice ; Brambilla, Don ; Kutlar, Abdullah ; Miller, Scott ; Vichinsky, Elliott ; Wang, Winfred ; Granger, Suzanne ; Adams, Robert J. / Longitudinal changes in ferritin during chronic transfusion : A report from the stroke prevention trial in sickle cell anemia (STOP). In: Journal of Pediatric Hematology/Oncology. 2002 ; Vol. 24, No. 4. pp. 284-290.
@article{e1ce98f3217e48379cde830c826959cf,
title = "Longitudinal changes in ferritin during chronic transfusion: A report from the stroke prevention trial in sickle cell anemia (STOP)",
abstract = "Purpose: Chronic red cell transfusion has been used for prevention of recurrent stroke in patients with sickle cell disease for three decades, and its effectiveness in primary prevention was recently shown. Iron overload, the inevitable result of chronic transfusion, is commonly monitored with serum ferritin concentration. Patients and Methods: Sixty-one patients at high risk for stroke received chronic transfusion in a clinical trial of stroke prevention. A serum ferritin level of less than 500 ng/mL was required for study entry. Ferritin levels were obtained quarterly. Fifty patients who had four or more ferritin measurements were included in this analysis. Transfusions were administered as exchange or simple, with washed, reconstituted, or packed red blood cells, at the discretion of the site investigator. Results: Serum ferritin levels increased linearly with cumulative transfusion volume during the first four ferritin measurements, but the rate of increase varied widely among patients. Rates of increase varied similarly among 23 patients who received exclusively simple transfusion with packed red cells and in five patients who received exchange transfusions. Thirty-two patients received a total transfusion volume of more than 250 mL/kg. Ferritin continued to increase linearly after the first four measurements in 14, but the remaining 18 experienced a plateau before the level reached 3,000 ng/mL. Six of those with a linear increase never reached a ferritin level of 3,000 ng/dL. Conclusions: There was strong intrapatient correlation between serum ferritin levels and volume transfused but wide interpatient variability early during chronic transfusion therapy. Intrapatient correlation declined at transfusion volumes of more than 250 mL/kg. Direct iron store assessment is needed to determine the clinical significance of serum ferritin variability.",
keywords = "Chronic transfusion, Iron overload, Serum ferritin, Sickle cell anemia, Stroke",
author = "Beatrice Files and Don Brambilla and Abdullah Kutlar and Scott Miller and Elliott Vichinsky and Winfred Wang and Suzanne Granger and Adams, {Robert J.}",
year = "2002",
month = "5",
day = "23",
doi = "10.1097/00043426-200205000-00013",
language = "English (US)",
volume = "24",
pages = "284--290",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Longitudinal changes in ferritin during chronic transfusion

T2 - A report from the stroke prevention trial in sickle cell anemia (STOP)

AU - Files, Beatrice

AU - Brambilla, Don

AU - Kutlar, Abdullah

AU - Miller, Scott

AU - Vichinsky, Elliott

AU - Wang, Winfred

AU - Granger, Suzanne

AU - Adams, Robert J.

PY - 2002/5/23

Y1 - 2002/5/23

N2 - Purpose: Chronic red cell transfusion has been used for prevention of recurrent stroke in patients with sickle cell disease for three decades, and its effectiveness in primary prevention was recently shown. Iron overload, the inevitable result of chronic transfusion, is commonly monitored with serum ferritin concentration. Patients and Methods: Sixty-one patients at high risk for stroke received chronic transfusion in a clinical trial of stroke prevention. A serum ferritin level of less than 500 ng/mL was required for study entry. Ferritin levels were obtained quarterly. Fifty patients who had four or more ferritin measurements were included in this analysis. Transfusions were administered as exchange or simple, with washed, reconstituted, or packed red blood cells, at the discretion of the site investigator. Results: Serum ferritin levels increased linearly with cumulative transfusion volume during the first four ferritin measurements, but the rate of increase varied widely among patients. Rates of increase varied similarly among 23 patients who received exclusively simple transfusion with packed red cells and in five patients who received exchange transfusions. Thirty-two patients received a total transfusion volume of more than 250 mL/kg. Ferritin continued to increase linearly after the first four measurements in 14, but the remaining 18 experienced a plateau before the level reached 3,000 ng/mL. Six of those with a linear increase never reached a ferritin level of 3,000 ng/dL. Conclusions: There was strong intrapatient correlation between serum ferritin levels and volume transfused but wide interpatient variability early during chronic transfusion therapy. Intrapatient correlation declined at transfusion volumes of more than 250 mL/kg. Direct iron store assessment is needed to determine the clinical significance of serum ferritin variability.

AB - Purpose: Chronic red cell transfusion has been used for prevention of recurrent stroke in patients with sickle cell disease for three decades, and its effectiveness in primary prevention was recently shown. Iron overload, the inevitable result of chronic transfusion, is commonly monitored with serum ferritin concentration. Patients and Methods: Sixty-one patients at high risk for stroke received chronic transfusion in a clinical trial of stroke prevention. A serum ferritin level of less than 500 ng/mL was required for study entry. Ferritin levels were obtained quarterly. Fifty patients who had four or more ferritin measurements were included in this analysis. Transfusions were administered as exchange or simple, with washed, reconstituted, or packed red blood cells, at the discretion of the site investigator. Results: Serum ferritin levels increased linearly with cumulative transfusion volume during the first four ferritin measurements, but the rate of increase varied widely among patients. Rates of increase varied similarly among 23 patients who received exclusively simple transfusion with packed red cells and in five patients who received exchange transfusions. Thirty-two patients received a total transfusion volume of more than 250 mL/kg. Ferritin continued to increase linearly after the first four measurements in 14, but the remaining 18 experienced a plateau before the level reached 3,000 ng/mL. Six of those with a linear increase never reached a ferritin level of 3,000 ng/dL. Conclusions: There was strong intrapatient correlation between serum ferritin levels and volume transfused but wide interpatient variability early during chronic transfusion therapy. Intrapatient correlation declined at transfusion volumes of more than 250 mL/kg. Direct iron store assessment is needed to determine the clinical significance of serum ferritin variability.

KW - Chronic transfusion

KW - Iron overload

KW - Serum ferritin

KW - Sickle cell anemia

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0036255547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036255547&partnerID=8YFLogxK

U2 - 10.1097/00043426-200205000-00013

DO - 10.1097/00043426-200205000-00013

M3 - Article

VL - 24

SP - 284

EP - 290

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -